Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma
Clinical trial NCT04231370 · UNKNOWN
Trial details
- NCT number
- NCT04231370
- Sponsor
- Beijing Tongren Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2022-02-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.